ArcticZymes Technologies - Director's Dealing 2018

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 14. May 2018) The following primary insiders of Biotec Pharmacon has

today 14. May 2018 bought the following shares:

Christian Jørgensen, CEO of Biotec Pharmacon has purchased 15.000 shares in

Biotec Pharmacon at NOK 6.45 per share. After this transaction holds Mr.

Jørgensen 77.000 shares and right to receive 500.000 options in Biotec

Pharmacon.

Børge Sørvoll, CFO of Biotec Pharmacon has purchased 8.000 shares in Biotec

Pharmacon at NOK 6.44 per share. After this transactions holds Mr. Sørvoll

25.428 shares and 70.000 options in Biotec Pharmacon.

Stuart Devine. VP Marketing, Woulgan has purchased 16.099 shares in Biotec

Pharmacon at NOK 6.70 per share. After this transactions holds Mr. Devine 61.286

shares and 30.000 options in Biotec Pharmacon.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187

AI assistant